ClinicaSpace.com
Clinical Research
News & Careers
 
Search the Site
    
 
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login           Employers:  Register | Login   
 Top Breaking News
 Tuesday, March 31, 2015




 Yesterday's Most Popular News 
New Test To Revolutionize Disease Detection In People, Crops And Stock, University of Queensland Study

Pfizer (PFE) Ad Spending Dwarfs Competitors

Adamis (ADMP) Plummets More Than 30% After FDA Rejects Its Allergy Shot Application

BioDelivery Sciences International (BDSI) Clonidine Topical Gel Fails Phase III, Shares Plunge

The 90/10 Rule: Cheat Meals Actually Boost Your Metabolism And Help You Lose Weight, Seton Hall University Study

Is Hummus Good For You? 6 Health Issues The Superfood Dip Can Treat

Ohr Pharma (OHRP)'s OHR-102 Fails in Phase II, Shares Plunge

GENFIT (ALGFT)'s GFT505 Misses Target in Phase IIB But Hopes to Proceed to Phase III

Novo Nordisk A/S (NVO) Soars on Plans to Resubmit NDAs of Tresiba and Ryzodeg in U.S.

Consuming Eggs With Raw Vegetables Increases Nutritive Value, Purdue University Study


 
-

 Featured Stories
 
New Study Recommends Early Introduction Of Peanuts To Prevent Allergies, Loyola University Health System Reveals
Saccharin Shows Promise As Cancer Inhibitor, University of Florida Researchers Find
Pesticides On Fruits, Veggies Linked With Poorer Semen Quality
New Genetic Link Found For Alcohol-Related Liver Cirrhosis, University of Cincinnati Study
Short Bouts Of High-Intensity Exercise Before A Fatty Meal Best For Promoting Vascular Health In Youth, University of Exeter Study
New Liver Cancer Report, New Links Emerge: Coffee Is Protective, Obesity Increases Risk, World Cancer Research Fund International Reveals
Smartphone Use Changing Our Brain And Thumb Interaction, Say University of Zurich Researchers
Ozone Air Pollution Could Harm Women's Fertility, Pennsylvania State University College Of Medicine Study
More Featured Stories

  Today's Top Jobs

 Featured Employer
About Genzyme Genzyme is committed to discovering and delivering transformative therapies for patients with rare and special unmet medical needs, providing hope where there was none before. Genzyme has pioneered the development and delivery of transformative therapies for over 30 years. Founded in 1981 in Boston, Massachusetts, Genzyme evolved from a tiny start-up with just a handful of employees to one of the world's leading biotech companies. Acquired by Sanofi in 2011, Genzyme now benefits from the reach and resources of one of the world’s largest pharmaceutical companies, with a shared commitment to improving the lives of patients. Genzyme has long been known for our expertise in the class of rare genetic diseases known as lysosomal storage disorders (LSDs). LSDs remain the heart of our company today, but we have also expanded – through both in-house development and strategic acquisitions and partnerships – to other disease areas such as thyroid cancer and multiple sclerosis. Learn more at www.jobsatgenzyme.com. Follow our jobs on Twitter www.twitter.com/genzymejobs. Follow us on LinkedIn http://www.linkedin.com/company/genzyme. About Sanofi Sanofi, a global and diversified healthcare leader, discovers, develops and distributes therapeutic solutions focused on patients’ needs. Sanofi has core strengths in the field of healthcare with seven growth platforms: diabetes solutions, human vaccines, innovative drugs, rare diseases, consumer healthcare, emerging markets, and animal health. Sanofi is listed in Paris (EURONEXT: SAN) and in New York (NYSE: SNY).

Show me jobs for this employer

 Careers
 
More Career Tips